Bone marrow transplantation for paediatric AML in first remision: A systematic review and meta-analysis

Bone Marrow Transplantation

Volumn 29, Issue 10, 2002, Pages 843-852

  Bleakley, M ^a   Lau, L ^a   Shaw, P J ^a,b   Kaufman, A ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ABMT; AML; Meta analysis; Pediatric; Systematic review

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HUMAN; META ANALYSIS; RISK FACTOR; TREATMENT OUTCOME; ACUTE MYELOBLASTIC LEUKEMIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; HISTOCOMPATIBILITY; INTERMETHOD COMPARISON; PATIENT INFORMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; DISEASE-FREE SURVIVAL; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; HUMAN; SUPPORT, NON-U.S. GOV'T;

BLEOMYCIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; VINBLASTINE;

EID: 0035998376     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703528     Document Type: Article

References (41)

1. Treatment of childhood leukemia
2. Acute myelogenous leukemia
3. How to avoid bias when comparing bone marrow transplantation with chemotherapy
4. Bone marrow transplantation for acute myeloblastic leukemia: An EBMT Leukemia Working Party prospective analysis from HLA typing
5. Diagnosis and treatment of childhood acute myelogenous leukemia
6. Tailoring the treatment of acute myeloid leukemia
7. Acute leukemia in children
8. Acute myeloid leukemia
9. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia
10. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood
11. Timed-sequential induction therapy improves post-remission outcome in acute myeloid leukemia: A report from the Children's Cancer Group
12. Aggressive post-remission (REM) chemotherapy is better than autologous bone marrow transplantation (BMT) and allogeneic BMT is superior to both in children with acute myeloid leukemia (AML)
13. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: Results of the United Kingdom Medical Research Council's 10th AML trial
14. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukemia in first remission: Results of MRC AML 10 trial
15. Outcome for children with relapsed acute myeloid leukemia following initial therapy in the Medical Research Council (MRC) AML 10 trial
16. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukemia derived from the UK MRC 10 trial
17. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78
18. Definition of a standard-risk group in children with AML
19. Statistical aspects of the analysis of data from retrospective studies of disease
20. Meta-analysis in clinical trials
21. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
22. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia; a Children's Cancer Group study
23. Childhood acute myeloid leukemia; outcome in a single centre using chemotherapy and consolidation with busulphan/cyclophosphamide for bone marrow transplantation
24. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission
25. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Children's Cancer Group pilot study
26. Therapy of acute myeloid leukemia in children-results of the AML II/87 multicenter study
27. Allogeneic bone marrow transplantation vs autologous bone marrow transplantation vs chemotherapy in childhood acute myeloid leukemia
28. Bone marrow transplantation for the treatment of childhood acute myelogenous leukemia - The MSKCC experience
29. A population-based study of 272 children with acute myeloid leukemia treated on two consecutive protocols with different intensity; best outcome in girls, infants, and children with down's syndrome
30. Allogeneic and autologous bone marrow transplantation for acute non-lymphoblastic leukemia
31. Prospective comparison between postinduction chemotherapy and various types of stem cell transplants for childhood acute myeloid leukemia using Japan cooperative protocols ANLL91
32. Treatment of childhood acute myelogenous leukemia with protocol ANLL93 containing allogeneic and autologous stem cell transplantation during first remission
33. Myelogenous leukemia in children
34. Autologous vs allogeneic BMT after post induction intensification therapy in AML in children
35. Individual patient data meta-analyses in cancer
36. Practical methodology of meta-analyses (overviews) using updated individual patient data
37. Meta-analysis of the literature or of individual patient data: Is there a difference?
38. Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies
39. A systematic collaborative overview of randomised trials comparing idarubicin aith daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia
40. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults
41. Adjuvant chemotherapy for soft tissue sarcoma: Review and meta-analysis of the published results of randomised clinical trials